Raine T, Danese S, Schreiber S, Gao X, et al. Corticosteroid-sparing effects of risankizumab versus ustekinumab in patients with moderately to severely active Crohn's disease: post hoc results from the phase 3b SEQUENCE trial. J Crohns Colitis 2026;20:jjag104.
PMID: 42479626